574 filings
Page 4 of 29
8-K
hlxcrkf36w0tuizvg3ss
11 May 23
Agile Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Update
4:15pm
8-K
f7gvevu04l9ksuztmnf
28 Apr 23
Agile Therapeutics Announces Preliminary Expectations for First Quarter 2023
4:40pm
ARS
log a0akck24
28 Apr 23
Annual report to shareholders
8:21am
8-K
su7i2vevhul8w wl
26 Apr 23
Other Events
4:59pm
UPLOAD
e7ovvamraxahadixr4h
19 Apr 23
Letter from SEC
12:00am
424B5
6o2kvr9hazo1tmj4yotj
11 Apr 23
Prospectus supplement for primary offering
9:02pm
8-K
xuk9bjrbwo50zhgs
10 Apr 23
Agile Therapeutics Announces 1-FOR-50 Reverse Stock Split
5:16pm
8-K
6namuza
30 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
g9i hetds
22 Mar 23
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
4:15pm
8-K
ros 9lpt87l9jl87
14 Mar 23
Departure of Directors or Certain Officers
4:29pm
8-K
mfepkpw3jb
27 Feb 23
Agile Therapeutics Granted 180-DAY Extension by Nasdaq to Meet the Minimum Bid Price Requirement
8:30am
SC 13G/A
onsqytdou
14 Feb 23
AGILE THERAPEUTICS / PERCEPTIVE ADVISORS ownership change
2:31pm
SC 13G/A
rfoqv7iwpyl3kly03c
13 Feb 23
AGILE THERAPEUTICS / Lind Global Fund II ownership change
4:33pm
SC 13G/A
nbuwb1pgmm2ugk64
8 Feb 23
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:06am
8-A12G
f1ei 4ny2n4
26 Jan 23
Registration of securities
5:20pm
8-K
jcx8b rlqam5hgwiz
26 Jan 23
Agile Therapeutics Announces Distribution of Series C Preferred Stock to Its Holders of Common Stock
5:11pm